Role of Histone Deacetylase Inhibitors in Relapsed Refractory Multiple Myeloma: A Focus on Vorinostat and Panobinostat
Pharmacotherapy - United States
doi 10.1002/phar.1671
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 1, 2015
Authors
Publisher
Wiley